Comparison of 18F-Fluorothymidine and 18F-Fluorodeoxyglucose PET/CT in Delineating Gross Tumor Volume by Optimal Threshold in Patients With Squamous Cell Carcinoma of Thoracic Esophagus
- 15 March 2010
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 76 (4) , 1235-1241
- https://doi.org/10.1016/j.ijrobp.2009.07.1681
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Study to Determine Adequate Margins in Radiotherapy Planning for Esophageal Carcinoma by Detailing Patterns of Recurrence After Definitive ChemoradiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2009
- Using 18F-Fluorodeoxyglucose Positron Emission Tomography to Estimate the Length of Gross Tumor in Patients With Squamous Cell Carcinoma of the EsophagusInternational Journal of Radiation Oncology*Biology*Physics, 2009
- Improving Observer Variability in Target Delineation for Gastro-oesophageal Cancer—the Role of 18Ffluoro-2-deoxy-d-glucose Positron Emission Tomography/Computed TomographyClinical Oncology, 2008
- A Multicenter Clinical Trial on the Diagnostic Value of Dual-Tracer PET/CT in Pulmonary Lesions Using 3′-Deoxy-3′-18F-Fluorothymidine and 18F-FDGJournal of Nuclear Medicine, 2008
- Diagnostic and Prognostic Value of 18F-FDG PET/CT for Patients with Suspected Recurrence from Squamous Cell Carcinoma of the EsophagusJournal of Nuclear Medicine, 2007
- Pathological analysis of clinical target volume margin for radiotherapy in patients with esophageal and gastroesophageal junction carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 2007
- Considerations in Treatment Planning for Esophageal CancerSeminars in Radiation Oncology, 2007
- Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Dose–response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Evaluation of Response to Neoadjuvant Therapy by Quantitative 2-Deoxy-2-[18F]Fluoro-D-Glucose with Positron Emission Tomography in Patients with Esophageal CancerMolecular Imaging & Biology, 2002